Skip to main content
  • Home
  • About
    • Overview
    • Directors & management
  • Platform
    • LentiVector® platform
    • TRiP SystemTM
    • LentiStableTM
    • SecNucTM
    • Process development
    • Analytics
    • Commercially approved vectors
    • Automation and System Integration
    • Digitalisation and Machine Learning
  • Pipeline
  • Bioprocessing
  • Investors
    • Investors homepage
    • Results, reports, presentations & webcasts
    • Shareholder meetings, circulars & prospectuses
    • Regulatory news
    • Share price information
    • Financial calendar
    • Analyst coverage
    • Registrars
    • Investor contacts
    • Corporate governance
    • Board committees
    • Warning to shareholders
    • Responsible business
  • News & events
    • Press releases
    • Events
    • Multimedia
    • Media contact details
  • Careers
  • Contact
  • Search
Loading...

About Oxford Biomedica

Overview

Pipeline

We are working on several internal product candidates and have interests in an expanding range of partner programmes

Bioprocessing

Our bioprocessing expertise and facilities support both our own and our partners’ product development

Press releases

Prime Minister Boris Johnson formally opens Oxford Biomedica’s manufacturing facility Oxbox

18 January 2021

Oxford Biomedica notes AstraZeneca’s COVID-19 vaccine has been authorised for emergency supply in the UK

30 December 2020

John Dawson named Executive of the Year for Companies <$10bn at the Annual Scrip Awards 2020

03 December 2020

More press releases

Share price

See full chart

Latest annual report

default image

Go to downloads

Oxford Biomedica plc
Windrush Court
Transport way
Oxford OX4 6LT
United Kingdom

+44 (0) 1865 783 000

Contact Us

  • © 2019 Oxford Biomedica
  • Legal
  • Privacy notice
  • Modern slavery act statement
  • Sitemap
  • Scientific branding by thinkerdoer
Close